K. Degroot et al., THERAPY FOR THE MAINTENANCE OF REMISSION IN 65 PATIENTS WITH GENERALIZED WEGENER GRANULOMATOSIS - METHOTREXATE VERSUS TRIMETHOPRIM SULFAMETHOXAZOLE/, Arthritis and rheumatism, 39(12), 1996, pp. 2052-2061
Objective. To compare the efficacy of low-dose intravenous (IV) methot
rexate (MTX; 0.3 mg/kg once weekly), both with and without concomitant
prednisone, versus daily oral trimethoprim/sulfamethoxazole (T/S; 160
mg of trimethoprim + 800 mg of sulfamethoxazole twice a day), with an
d without prednisone, in maintaining remission in patients with genera
lized Wegener's granulomatosis (WG). Methods. In this study, 65 patien
ts with generalized WG whose disease had entered remission,vith cyclop
hosphamide (CYC) and prednisone therapy were started on one of the fol
lowing remission-maintenance regimens: MTX alone (group A; n = 22), T/
S alone (group B; n = 24), MTX plus concomitant prednisone (group C; n
= 11), and T/S plus concomitant prednisone (group D; n = 8), Clinical
, radiographic, and seroimmunologic data were evaluated to assess the
efficacy of the 4 regimens and to seek possible predictive factors con
cerning outcome in each group. Results. Partial or complete remission
was maintained in 86% of the patients in group A, but in only 58% of t
hose in group B (P < 0.05), In group C, 91% of patients remained in re
mission, which is in sharp contrast to group D, in which all patients
experienced a relapse after a median of 14.5 months (P < 0.005), Side
effects occurred twice as often with MTX (n = 12) as with T/S (n = 6)
treatment and could usually be resolved by supplemental folinic acid,
Two patients taking MTX and 3 patients taking T/S were withdrawn from
the study medication because of side effects, In none of the patients
were the adverse effects life threatening, No statistically significan
t factors predictive of poor outcome emerged in any group. Conclusion.
Low-dose MTX was found to be superior to T/S for the safe and effecti
ve maintenance of remission in patients with generalized WG. The use o
f concomitant prednisone was not associated with a worse outcome with
MTX treatment, Since T/S, especially with concomitant prednisone, seem
ed to increase the chance of relapse, neither T/S alone nor T/S plus p
rednisone can be recommended for the maintenance of remission in patie
nts with generalized WG.